Advertisement

Personalized therapy in multiple myeloma according to patient age and vulnerability: a report of the European Myeloma Network (EMN)

Antonio Palumbo, Sara Bringhen, Heinz Ludwig, Meletios A. Dimopoulos, Joan Bladé, Maria V. Mateos, Laura Rosiñol, Mario Boccadoro, Michele Cavo, Henk Lokhorst, Sonja Zweegman, Evangelos Terpos, Faith Davies, Christoph Driessen, Peter Gimsing, Martin Gramatzki, Roman Hàjek, Hans E. Johnsen, Fernando Leal Da Costa, Orhan Sezer, Andrew Spencer, Meral Beksac, Gareth Morgan, Hermann Einsele, Jesus F. San Miguel and Pieter Sonneveld

Article Information

Citation 
vol. 118 no. 17 4519-4529
PubMed 

Print ISSN 
Online ISSN 
History 
  • Submitted June 8, 2011
  • Accepted August 4, 2011
  • Published online October 27, 2011.

Article Versions


Contributors 
  • Antonio Palumbo, 1Myeloma Unit, Division of Hematology, University of Torino, Azinda Ospedaliero-Universitaria S. Giovanni Battista, Torino, Italy;
  • Sara Bringhen, 1Myeloma Unit, Division of Hematology, University of Torino, Azinda Ospedaliero-Universitaria S. Giovanni Battista, Torino, Italy;
  • Heinz Ludwig, 2Department of Medicine I, Center of Oncology and Hematology, Wilhelminenspital, Vienna, Austria;
  • Meletios A. Dimopoulos, 3Department of Clinical Therapeutics, University of Athens School of Medicine, Alexandra General Hospital, Athens, Greece;
  • Joan Bladé, 4Department of Hematology, Hospital Clinic, Barcelona, Spain;
  • Maria V. Mateos, 5Servicio de Hematología, Hospital Universitario de Salamanca, and Centro de Investigacion del Cancer, Instituto de Biologia Moleculary Cellular del Cancer (Universdad de Salamanca–Consejo Superior de Investigaciones Cientifica), Salamanca, Spain;
  • Laura Rosiñol, 6Hospital Clinic, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain;
  • Mario Boccadoro, 1Myeloma Unit, Division of Hematology, University of Torino, Azinda Ospedaliero-Universitaria S. Giovanni Battista, Torino, Italy;
  • Michele Cavo, 7Istituto di Ematologia Seràgnoli, Università degli Studi di Bologna, Bologna, Italy;
  • Henk Lokhorst, 8Department of Hematology, University Medical Center Utrecht, Utrecht, The Netherlands;
  • Sonja Zweegman, 9Department of Hematology, VU University Medical Center, Amsterdam, The Netherlands;
  • Evangelos Terpos, 3Department of Clinical Therapeutics, University of Athens School of Medicine, Alexandra General Hospital, Athens, Greece;
  • Faith Davies, 10Institute of Cancer Research and Royal Marsden Hospital, London, United Kingdom;
  • Christoph Driessen, 11Department of Oncology/Hematology, Kantonsspital St Gallen, St Gallen, Switzerland;
  • Peter Gimsing, 12Department of Haematology, University Hospital of Copenhagen at Rigshospitalet, Copenhagen, Denmark;
  • Martin Gramatzki, 13Division of Stem Cell Transplantation and Immunotherapy, 2nd Department of Medicine, University of Kiel, Kiel, Germany;
  • Roman Hàjek, 14Department of Internal Medicine and Hemato-oncology, Faculty of Hospital Brno and Babak Research Institute, Faculty of Medicine, Masaryk University, Brno-město, Czech Republic;
  • Hans E. Johnsen, 15Aalborg Hospital, Aarhus University Hospital, Aalborg, Denmark;
  • Fernando Leal Da Costa, 16Department of Hematology, Instituto Português de Oncologia, Lisbon, Portugal;
  • Orhan Sezer, 17Department of Hematology and Oncology, University Medical Center, Hamburg, Germany;
  • Andrew Spencer, 18Malignant Hematology and Stem Cell Transplantation Service, Alfred Hospital, Victoria, Australia;
  • Meral Beksac, 19Department of Hematology, Ankara University, Ankara, Turkey;
  • Gareth Morgan, 10Institute of Cancer Research and Royal Marsden Hospital, London, United Kingdom;
  • Hermann Einsele, 20Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany; and
  • Jesus F. San Miguel, 5Servicio de Hematología, Hospital Universitario de Salamanca, and Centro de Investigacion del Cancer, Instituto de Biologia Moleculary Cellular del Cancer (Universdad de Salamanca–Consejo Superior de Investigaciones Cientifica), Salamanca, Spain;
  • Pieter Sonneveld, 21Department of Hematology, University Hospital Rotterdam, Rotterdam, The Netherlands

Altmetric.com Statistics

The Altmetric score is a weighted count of online attention designed to reflect the volume and reach of online engagement surrounding an individual research output